Clinical Trial Update: TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating TSL2109 capsules in advanced solid tumors includes safety, tolerability, pharmacokinetics, and preliminary efficacy assessments.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• TSL2109 Capsules

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Metastatic Castration-Resistant Prostate Cancer Patients | Phase 1 | Status: RECRUITING